General Information of the Compound
| Compound ID |
CP0495612
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(3E,5R,8R,9R,10R,12R,13R,14R,17S)-3-[(2,4-difluorophenyl)hydrazinylidene]-4,4,8,10,14-pentamethyl-17-[(2R)-2,6,6-trimethyloxan-2-yl]-1,2,5,6,7,9,11,12,13,15,16,17-dodecahydrocyclopenta[a]phenanthren-12-ol
Show/Hide
|
||||||||||||||||||
| Formula |
C36H54F2N2O2
|
||||||||||||||||||
| Molecular Weight |
584.836
|
||||||||||||||||||
| Canonical SMILES |
C[C@@]12CC[C@@H]([C@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC\C(=N/Nc4ccc(F)cc4F)C(C)(C)[C@@H]3CC[C@@]21C)[C@@]1(C)CCCC(C)(C)O1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C36H54F2N2O2/c1-31(2)15-9-16-36(8,42-31)23-12-18-35(7)30(23)26(41)21-28-33(5)17-14-29(32(3,4)27(33)13-19-34(28,35)6)40-39-25-11-10-22(37)20-24(25)38/h10-11,20,23,26-28,30,39,41H,9,12-19,21H2,1-8H3/b40-29+/t23-,26+,27-,28+,30-,33-,34+,35+,36+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
VBROIZGILLQPNF-IXYQXGNYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound